First Author: A.O.Saatci TURKEY
Co Author(s): R. Yıldırım M. Parlak G. Cetin A. Yaman 0 0 0 0 0 0 0 0 0
Back to previous
To report the prevalence of postoperative retinal tear or rhegmatogenous retinal detachment secondary to intravitreal injections.
Retrospective clinical study and case series
The operating logs between January 2004 and May 2013 were evaluated and medical records of patients who received intravitreal injections were investigated retrospectively. All patients were from the practice of a single retina specialist. Patients with follow-up time less than 6 months were excluded.
During the study interval, a total of 3907 intravitreal injections were performed in 1049 eyes of 784 patients. The mean number of injection per eye was 3.72 ± 3.43 (Range:1-22). The mean age of the participants was 67.03 ± 13.56 (Range: 5-94 years). The mean follow-up time was 31.98 ± 22.86 months (Range: 6-144 months). Three hundred sixty-eight patients (47%) were female and 416 (53%) male. The overall prevalence of retinal break or rhegmatogenous retinal detachment was 0.077% per injection (3 of 3907 injections) and 0.29% per eye (3 of 1049 eyes).
Retinal tear or rhegmatogenous detachment is a rare complication that may occur after each intravitreal injection. This complication can be seen despite the excellence of current injection technique. Precautions should be taken especially in patients having predisposing conditions such as high myopia or any other underlying diseases.